Skip to main content

Advertisement

Log in

Acute endovascular stroke therapy

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

A decade after the US Food and Drug Administration (FDA) approved intravenous tissue plasminogen activator for treatment of acute ischemic stroke, the public health impact of this treatment on stroke outcome remains limited. The extremely small time window for treatment and very low recanalization rates in large artery strokes are its major shortcomings. Endovascular therapies for the treatment of acute stroke have rapidly evolved during this time period and may overcome these limitations. FDA approval of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) concentric retriever in August 2004 for the treatment of occluded brain arteries has spurred trials of newer devices for mechanical thrombolysis in acute stroke. At present, there are two major National Institutes of Health-sponsored randomized controlled trials testing endovascular treatments in acute stroke. In this article, we provide an experience-guided review of the current approach to the endovascular treatment of acute ischemic stroke and current evidence for various strategies. We first emphasize the key aspects of patient selection, including the increasingly central role of perfusion/diffusion imaging. The technical aspects of chemical, mechanical, ultrasound-based, and multimodal approaches are provided along with the authors’ own experiences. Most of the endovascular modalities tested in clinical trials show recanalization rates in the range of 50% to 65%. However, no one modality is clearly superior. In practice, multimodal treatment strategy is often employed to achieve rapid recanalization of occluded cerebral vessels and minimize chances of hemorrhage. This may become the standard of care in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Katzan IL, Furlan AJ, Lloyd LE, et al.: Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000, 283:1151–1158.

    Article  PubMed  CAS  Google Scholar 

  2. Engelstein E, Margulies J, Jeret JS: Lack of t-PA use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria. Am J Emerg Med 2000, 18:257–260.

    Article  PubMed  CAS  Google Scholar 

  3. Kidwell CS, Saver JL, Mattiello J, et al.: Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance perfusion imaging. Ann Neurol 2000, 47:462–469.

    Article  PubMed  CAS  Google Scholar 

  4. Wolpert S, Bruckmann H, Greenlee R, et al., and the rt-PA Acute Stroke Study Group: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. Am J Neuroradiol 1993, 14:3–13.

    PubMed  CAS  Google Scholar 

  5. Nesbit G, Luh G, Tien R, Barwell S: New and future endovascular treatment strategies for acute ischemic stroke. JVIR Supplement 2004, 15:S103-S110.

    Google Scholar 

  6. Shih LC, Saver JL, Alger JR, et al.: Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003, 34:1425–1430.

    Article  PubMed  Google Scholar 

  7. Kim EY, Na DG, Kim SS, et al.: Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusionweighted imaging and early parenchymal enhancement. Am J Neuroradiol 2005, 26:1050–1055.

    PubMed  Google Scholar 

  8. Kassner A, Roberts T, Taylor K, et al.: Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. Am J Neuroradiol 2005, 26:2213–2217.

    PubMed  Google Scholar 

  9. Bergui M, Stura G, Daniele D, et al.: Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke 2006, 37:145–150.

    Article  PubMed  Google Scholar 

  10. Favrole P, Saint-Maurice JP, Bousser MG, Houdart E: Use of mechanical extraction devices in basilar artery occlusion. J Neurol Neurosurg Psychiatry 2005, 76:1462–1464.

    Article  PubMed  CAS  Google Scholar 

  11. Brott T, Adams HP Jr, Olinger CP, et al.: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864–870.

    PubMed  CAS  Google Scholar 

  12. del Zoppo GJ, Poeck K, Pessin MS, et al.: Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992, 32:78–86.

    Article  PubMed  Google Scholar 

  13. Lewandowski CA, Frankel M, Tomsick TA, et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30:2598–2605.

    PubMed  CAS  Google Scholar 

  14. Fischer U, Arnold M, Nedeltchev K, et al.: NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005, 36:2121–2125.

    Article  PubMed  Google Scholar 

  15. Go JL, Zee CS: Unique CT imaging advantages. Hemorrhage and calcification. Neuroimaging Clin North Am 1998, 8:541–558.

    CAS  Google Scholar 

  16. Roberts HC, Dillon WP, Furlan AJ, et al.: Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke 2002, 33:1557–1565.

    Article  PubMed  Google Scholar 

  17. Qureshi AI: Endovascular revascularization of symptomatic acute extracranial internal carotid artery occlusion. Stroke 2005, 36:2335–2336.

    Article  PubMed  Google Scholar 

  18. Lev MH, Farkas J, Rodriguez VR, et al.: CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 2001, 25:520–528.

    Article  PubMed  CAS  Google Scholar 

  19. Josephson SA, Dillon WP, Smith WS: Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology 2005, 64:1805–1806. This article addresses the incidence of dye nephropathy when attempting to institute CT angiography as part of an emergency room stroke evaluation protocol.

    Article  PubMed  Google Scholar 

  20. Wintermark M, Reichhart M, Thiran JP, et al.: Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002, 51:417–432.

    Article  PubMed  Google Scholar 

  21. Wintermark M, Flanders AE, Velthuis B, et al.: Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006, 37:979–985.

    Article  PubMed  Google Scholar 

  22. Hjort N, Butcher K, Davis SM, et al.: UCLA Thrombolysis Investigators: Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005, 36:388–397.

    Article  PubMed  CAS  Google Scholar 

  23. Rovira A, Orellana P, Alvarez-Sabin J, et al.: Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 2004, 232:466–473.

    Article  PubMed  Google Scholar 

  24. Schellinger PD, Chalela JA, Kang DW, et al.: Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. Am J Neuroradiol 2005, 26:618–624.

    PubMed  Google Scholar 

  25. Cho KH, Kim JS, Kwon SU, et al.: Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005, 36:2379–2383.

    Article  PubMed  Google Scholar 

  26. Intra-arterial Prourokinase for Acute Ischemic Stroke. The PROACT II Study: a randomized controlled trial. JAMA 1999, 282:2003–2011.

  27. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581–1587.

  28. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004, 35:904–911. This paper outlines an approach to the combined use of IV and intra-arterial tPA that is used in many centers.

    Article  Google Scholar 

  29. Adams HP: Abciximab in Emergent Stroke Treatment Trial - II. Presented at the 30th International Stroke Conference. February 2005.

  30. Wechsler LR: Does the Merci Retriever work? Against. Stroke 2006 37:1341–1342; discussion 1342–1343.

    Article  PubMed  Google Scholar 

  31. Wade S, Smith R, for the Multi MERCI investigators: Safety of mechanical thrombectomy and intravenous tissue plasminogen activatro in acute ischemic stroke. results of the Multi MERCI Trial, Part I. Am J Neuroradiol 2006, 27:1177–1182. This trial formed the basis for FDA approval of the first device for cerebral clot extraction. The device is now in widespread use.

    Google Scholar 

  32. Levy EI, Ecker RD, Horowitz MB, et al.: Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006, 58:458–463; discussion 458–463.

    PubMed  Google Scholar 

  33. Jovin TG, Gupta R, Uchino K, et al.: Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke 2005, 36:2426–2430.

    Article  PubMed  Google Scholar 

  34. Alexandrov AV, Molina CA, Grotta JC, et al.: CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004, 351:2170–2178.

    Article  PubMed  CAS  Google Scholar 

  35. Mahon BR, Nesbit GM, Barnwell SL, et al.: North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. Am J Neuroradiol 2003, 24:534–538.

    PubMed  Google Scholar 

  36. IMS II Investigators: Preliminary results of the IMS II trial [abstract]. Stroke 2006, 37:708.

    Article  Google Scholar 

  37. Saver JL: Does the Merci Retriever work? For. Stroke 2006, 37:1340–1341; discussion 1342–1343.

    Article  PubMed  Google Scholar 

  38. Bellon RJ, Putman CM, Budzik RF, et al.: Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. Am J Neuroradiol 2001, 22:526–530.

    PubMed  CAS  Google Scholar 

  39. Mayer TE, Hamann GF, Brueckmann HJ: Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke 2002, 33:2232–2235.

    Article  PubMed  Google Scholar 

  40. Abou-Chebl A, Bajzer CT, Krieger DW, et al.: Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke 2005, 36:2286–2288.

    Article  PubMed  CAS  Google Scholar 

  41. Gupta R, Vora NA, Horowitz MB, et al.: Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke 2006, 37:986–990.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dileep R. Yavagal MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edgell, R., Yavagal, D.R. Acute endovascular stroke therapy. Curr Neurol Neurosci Rep 6, 531–538 (2006). https://doi.org/10.1007/s11910-006-0057-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-006-0057-0

Keywords

Navigation